- Intraductal malignant tumors in the liver mimicking cholangiocarcinoma: Imaging features for differential diagnosis
-
Kim AY, Jeong WK
- KMID: 2363040
- Clin Mol Hepatol.
- 2016 Mar;22(1):192-197.
- doi: 10.3350/cmh.2016.22.1.192
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Percutaneous cryoablation for hepatocellular carcinoma
-
Song KD
- KMID: 2373157
- Clin Mol Hepatol.
- 2016 Dec;22(4):509-515.
- doi: 10.3350/cmh.2016.0079
Local ablation therapy is considered as a conventional treatment option for patients with early stage hepatocellular carcinoma (HCC). Although radiofrequency (RF) ablation is widely used for HCC, the use of... -
- CITED
-
- Close
- SHARE
-
- Close
- Aggressive tumor recurrence after radiofrequency ablation for hepatocellular carcinoma
-
Kang TW, Lim HK, Cha DI
- KMID: 2412121
- Clin Mol Hepatol.
- 2017 Mar;23(1):95-101.
- doi: 10.3350/cmh.2017.0006
Image-guided radiofrequency ablation (RFA) is an evolving and growing treatment option for patients with hepatocellular carcinoma (HCC) and hepatic metastasis. RFA offers significant advantages as it is less invasive than... -
- CITED
-
- Close
- SHARE
-
- Close
- Yttrium-90 Selective Internal Radiation Therapy with Glass Microspheres for Hepatocellular Carcinoma: Current and Updated Literature Review
-
Lee EW, Alanis L, Cho SK, Saab S
- KMID: 2455418
- Korean J Radiol.
- 2016 Aug;17(4):472-488.
- doi: 10.3348/kjr.2016.17.4.472
Hepatocellular carcinoma is the most common primary liver cancer and it represents the majority of cancer-related deaths in the world. More than 70% of patients present at an advanced stage,... -
- CITED
-
- Close
- SHARE
-
- Close
- Liver transplantation for advanced hepatocellular carcinoma
-
Lee HW, Suh KS
- KMID: 2373130
- Clin Mol Hepatol.
- 2016 Sep;22(3):309-318.
- doi: 10.3350/cmh.2016.0042
There has been ongoing debate that the Milan criteria may be too strict that a significant number of patients who could benefit from liver transplantation (LT) might have been excluded.... -
- CITED
-
- Close
- SHARE
-
- Close
- A concise review of updated guidelines regarding the management of hepatocellular carcinoma around the world: 2010-2016
-
Yu SJ
- KMID: 2363028
- Clin Mol Hepatol.
- 2016 Mar;22(1):7-17.
- doi: 10.3350/cmh.2016.22.1.7
Many guidelines for hepatocellular carcinoma (HCC) have been published and updated globally. In contrast to other cancers, there is a range of treatment options for HCC involving several multidisciplinary care... -
- CITED
-
- Close
- SHARE
-
- Close
- The role of scheduled second TACE in early-stage hepatocellular carcinoma with complete response to initial TACE
-
Kim JH, Sinn DH, Shin SW, Cho SK, Kang W, Gwak GY, Paik YH, Lee JH, Koh KC, Paik SW, Choi MS
- KMID: 2412113
- Clin Mol Hepatol.
- 2017 Mar;23(1):42-50.
- doi: 10.3350/cmh.2016.0058
BACKGROUND/AIMS: We investigated the outcomes of early-stage hepatocellular carcinoma (HCC) patients who showed a complete response (CR) to initial transarterial chemoembolization (TACE), with a focus on the role of scheduled... -
- CITED
-
- Close
- SHARE
-
- Close
